詳細検索結果
以下の条件での結果を表示する: 検索条件を変更
クエリ検索: "安藤" 医薬品
3,298件中 1-20の結果を表示しています
  • 江戸 清人,
    安藤
    崇仁
    医薬品
    情報学

    2017年 18 巻 4 号 N1_2-N4
    発行日: 2017年
    公開日: 2017/03/17
    ジャーナル フリー
  • ―消化性潰瘍治療薬を対象として―
    飯嶋 久志, 鷲尾 夢香
    医薬品
    情報学

    2021年 23 巻 1 号 26-31
    発行日: 2021/05/31
    公開日: 2021/06/25
    ジャーナル フリー

    Objective: Missing high evidence-level articles during a literature search inhibits the use of information useful for research programs and reviews. Checking the core journals included in the search results serves as a guide to determining the search’s appropriateness. This study specifically researched core journals on peptic ulcer remedies to verify the quality of articles included therein.

    Method: We searched for core journals on peptic ulcer remedies using Bradford’s law. To evaluate the quality of the articles included in the core journals, we examined the implementation rates of RCTs and the double-blind method.

    Results: We were able to verify Bradford curves from the extracted articles. Each journal group approximated the theoretical values based on proportional expressions. 2,164 occurrences of omeprazole, 1,109 occurrences of ranitidine, and 917 occurrences of cimetidine were extracted from the database. Two of the core journals were about omeprazole, three about ranitidine, and five about cimetidine. All core journals were specialty journals on the digestive system, except for The Lancet. The implementation rates of RCT and double-blind method comparison tests for the core journals tended to be higher than other journal groups.

    Conclusion: Quantitative processing of the clinical papers on each drug enabled us to identify appropriate core journals. Because the quality of this journal group tended to be higher than that of other groups, the search quality can be assured by checking the core journals included in search results.

  • 大内 隆宏, 平田 一耕, 村山 和真, 舟越 亮寛
    医薬品
    情報学

    2023年 24 巻 4 号 179-186
    発行日: 2023/02/28
    公開日: 2023/04/07
    ジャーナル フリー

    Objective: The success rate of third-line treatment for Helicobacter pylori (H. pylori) infection has been reported to depend on the use of antibacterial agents, potassium-competitive acid blockers, and proton pump inhibitors. However, there is insufficient information on the success rate of H. pylori treatment due to the differences in the clinically used drugs. Here, the factors influencing the success rate of third-line treatment for H. pylori infection was investigated.

    Methods: Patients aged 20 years or older, who had received third-line treatment for H. pylori infection from January 2013 to December 2021 at the Kameda Medical Center were included. The exclusion criteria were as follows: patients with unknown treatment results and discontinuation of treatment. The primary endpoint was treatment success rate, based on the differences in the treatment regimen and drug choice, which was retroactively investigated from medical records. Confounding factors were adjusted by multivariate logistic regression analysis.

    Results: Treatment regimens containing sitafloxacin resulted in higher treatment success rates (p<0.05). Multivariate logistic regression analysis showed that the administration of sitafloxacin was the only statistically significant factor influencing treatment success. However, vonoprazan also tended to influence treatment success.

    Conclusion: Treatment with sitafloxacin and vonoprazan increases the success rate of third-line treatment against H. pylori infection.

  • 秋山 滋男, 新井 克明, 輿石 徹, 石田 志朗, 倉田 なおみ
    医薬品
    情報学

    2019年 20 巻 4 号 220-226
    発行日: 2019/02/28
    公開日: 2019/03/21
    ジャーナル フリー

    Objective: We conducted a survey on drug information accumulated by pharmaceutical companies about the adequacy of administration of crushed or simply suspended internal medicines through enteral feeding tube, examination methods to confirm adequacy and inquiries from medical institutions to pharmaceutical companies about the adequacy of these methods.

    Methods: We sent a questionnaire to 162 pharmaceutical companies that sell internal medicines to collect information. The survey was conducted from May 1, 2016 to March 31, 2017.

    Results: The questionnaire response rate was 61% (99 companies responded). Eighty and 90 percent of the companies possessed information about the drug crushing methods and simple suspension methods used for administration of internal medicines,respectively. The type of information and examination methods used varied among the companies, was very limited, and was often limited to new drugs. The information acquisition rate about crushing methods was 69.3% in original examination methods of pharmaceutical companies. On the other hand, 90.3% of the information about simple suspension methods was obtained by the unified method of Hand Book of Simple Suspension Method.

    Conclusions: In the future, medical practice and patients will benefit if examination methods to confirm the adequacy of crushing and administration through feeding tubes are commonly and consistently obtained by pharmaceutical companies. Furthermore, it would be very useful for information of crushing methods and simple suspension methods to be included in package inserts and interview forms.

  • 志智 早織, 藤田 知子, 川上 絵梨子, 樋上 彰子, 橋本 大輔, 藤田(濱邊) 和歌子, 徳山 尚吾
    医薬品
    情報学

    2009年 11 巻 2 号 88-95
    発行日: 2009/11/30
    公開日: 2010/05/12
    ジャーナル フリー
    Objective: The importance of self-supervised health care is growing.  In this field, we thought that pharmacists working in the community pharmacy or drugstore could play important roles in the health supervision of local residents, since they are familiar with community.  Here, we examined the effectiveness of “healthcare workshop” or “information service” by drugstore pharmacists on the consciousness of local residents regarding their health or the role of drugstore pharmacists as supporter of their medical health care.
    Design and Methods: In the three branches of Yutaka pharmacy Ltd., we performed the “healthcare workshop” (4 times/ 6 months), “information service in regard to health or medical care” (about 10 times/day) and “distribution of medicine notebook” over 6 months.  To evaluate the effectiveness of these activities, the questionnaire was answered by the consumer in drugstores of the Yutaka pharmacy Ltd. before and after the “healthcare workshop” or “information service”.
    Results: The recognition of pharmacist in the drugstore was significantly improved (before: 23.4%, after 39.1%).   In addition, the need of information service by drugstore pharmacists also increased from 62.5% to 76.1%.  Furthermore, the bringing ratio of medicine notebook and the percentage of submission of medicine notebook to doctors were increased from 52.1% to 61.5% and from 40.0% to 55.6%, respectively, while the possessive ratio of medicine notebook was not changed.
    Conclusions: In the present study indicate that activities such as “healthcare workshop” and “information service” performed by pharmacists in drugstore are effective to provide many medical information extensively and to increase the need of information service by drugstore pharmacists in the local community.  In conclusion, continuance of these activities may important for drugstore pharmacists to be recognized as medical staff who support the health supervision of local residents in the future.
  • 出川 えりか,
    安藤
    崇仁,
    安藤
    正純, 加藤 剛, 嶋村 寿, 永田 あかね, 村野 哲雄, 林 広紹, 馬場 寛子, 齋藤 百枝美
    医薬品
    情報学

    2018年 20 巻 3 号 189-199
    発行日: 2018/11/30
    公開日: 2018/12/08
    ジャーナル フリー

    Objective: Caffeine may cause dependence and sleep disturbance, and interact with psychotropic drugs. Therefore, the caffeine intake of patients with mental disorders should be monitored. However, in Japan, there is no report on the effects of caffeine in mental disease patients or on their caffeine intake. Therefore, we conducted a questionnaire survey to clarify the perception of caffeine for psychiatric outpatients.

    Methods: We conducted an anonymous survey on caffeine recognition for outpatients at 8 medical institutions that advocate psychiatry.

    Results: We collected questionnaires from 180 people. The knowledge of foods containing caffeine tended to be high in those who had a positive attitude toward caffeine. More than 90% of those surveyed knew that coffee contains caffeine, but cocoa and jasmine tea were recognized by less than 25%. Of those surveyed, 39.4% consumed caffeine‐containing beverages at night. In addition, the rate of consumption of caffeine‐containing beverages tended to be higher at night because they had a positive attitude toward caffeine.

    Conclusion: The knowledge and intake situation of caffeine by patients with mental disorders differed depending on their interests and way of thinking about caffeine. As caffeine intake may influence psychiatric treatment, correct knowledge regarding caffeine is important.

  • 鈴木 信也, 川口 崇, 猪狩 賢蔵, 草野 淳一,
    安藤
    栄輝
    医薬品
    情報学

    2017年 18 巻 4 号 235-241
    発行日: 2017年
    公開日: 2017/03/17
    ジャーナル フリー
    Objective: Celecoxib has been reported to enhance the action of warfarin by inhibiting CYP2C9, its major hepatic drug-metabolizing enzyme, but sufficient information about the mechanism has not been obtained, especially in Japan.
    Methods: A study was conducted to investigate the prothrombin time international normalized ratio (PT-INR) and the warfarin sensitivity index (WSI) before and after concurrent administration of celecoxib, as well as the Drug Interaction Probability Scale (DIPS) scores to determine causality with drug interactions, in patients commencing concurrent therapy with celecoxib and warfarin at Kanagawa Prefectural Keiyukai Keiyu Hospital during the 4-year period from October 2011 to September 2015.
    Results: Analysis of 18 patients showed that the PT-INR increased significantly from 1.53±0.43 before concurrent therapy to 2.18±1.01 after concurrent therapy (p=0.0101).  The WSI also increased significantly from 0.76±0.50 before concurrent therapy to 1.01±0.65 after concurrent therapy (p=0.0044).  According to the DIPS scores, the causal relation was not rated as “Highly Probable” in any of the patients, while it was considered to be “Probable” in 3 patients, “Possible” in 10 patients, and “Doubtful” in 5 patients.
    Conclusion: The findings of this study suggested that when celecoxib treatment is initiated in patients who are already taking warfarin, attention must be paid to changes of coagulation profile, especially in elderly patients.
  • 平 井 み ど り
    医薬品
    情報学

    2015年 16 巻 4 号 N1-N3
    発行日: 2015/02/28
    公開日: 2015/03/10
    ジャーナル フリー
  • 井出 和希, 幾見 泰洋, 木内 亜弥, 曽根 順子, 小島 真, 山田 浩
    医薬品
    情報学

    2015年 16 巻 4 号 201-205
    発行日: 2015年
    公開日: 2015/03/10
    ジャーナル フリー
    Objective: To reveal the current use of medication notebooks in clinical practice and the differences in submission rates of medication notebooks among patients with different sociodemographic and medical characteristics.
    Methods: We conducted a survey of the submission rates by studying the medication history, from June 19, 2014, to July 3, 2014.
    Results: The overall submission rate of returning patients was 57.1% and the submission rate of patients who visit a single medical institution was significantly lower than patients who visit more than two (55.4% vs. 67.7%, p<0.001).  Multivariate logistic regression also indicated significant differences between the single and multiple medical institution visit group (adjusted OR=2.74 [95% CI: 1.93-3.89], p<0.001).  Submission rates for patients in their 20, 30, and 50 s who visit a single medical institution were lower than 40%.
    Conclusions: To improve the usefulness of the community pharmacy and increase the submission rate, we need to increase awareness of the importance of medication notebooks among patients who visit a single medical institution.  Additionally, future studies need to focus on factors such as age-related issues that might affect submission rates.
  • ―タクロリムスとアプレピタントの薬物相互作用に着目し薬学的支援を行った皮膚筋炎併発胃がんの 1 例―
    川上 恵, 北田 徳昭, 米澤 淳, 岡村 みや子, 尾崎 淳子, 池見 泰明, 中川 俊作, 今井 哲司, 中川 貴之, 土井 恵太郎, 秋月 修治, 武藤 学, 寺田 智祐
    医薬品
    情報学

    2023年 25 巻 2 号 83-90
    発行日: 2023/08/31
    公開日: 2023/09/15
    ジャーナル フリー

    Objective: In patients with specific backgrounds, comprehensive identification of health problems and proactive pharmacist intervention are crucial to providing safe and effective medical care. However, there are insufficient reports on chemotherapy regimen selection and supportive care management in patients taking immunosuppressants. In this study, to circumvent adverse events, pharmacists intervened with a patient administering tacrolimus (TAC) using known information, focusing on multiple factors attributable to the patient in addition to drug interactions.

    Methods: The patient was a male in their 70s who received palliative chemotherapy for gastric cancer during their dermatomyositis treatment with TAC. Pharmaceutical support for cancer chemotherapy was provided using the following four procedures: (1) Patient information was collected from interviews and electronic medical records to identify patient-specific problems; (2) Basic pharmacological information was collected from tertiary sources, focusing on the interaction between TAC and aprepitant (APR). Furthermore, clinical reports were collected, and the pharmacokinetic drug interaction significance classification system was used for quantitative predictions; (3) The information obtained in steps 1) and 2) was evaluated, and comprehensive proposals linked to the patient information were presented; (4) Adverse events, TAC blood level, and patient outcomes were monitored after treatment initiation.

    Results: A chemotherapy regimen consisting of S-1/oxaliplatin therapy without APR was selected. The adverse effects were controllable, and the treatment was completed without many adverse events. Meanwhile, TAC adherence was unaffected by cancer chemotherapy, and the TAC blood concentration or dose ratios were controlled within the same range as previously reported.

    Conclusion: In cancer chemotherapy, for cases with limited evidence or information, comprehensive pharmaceutical support was provided using known patient information, considering multiple patient factors. This report is beneficial as an example of supportive care management by a pharmacist and contributes to providing optimal service in cases with specific backgrounds.

  • 酒井 隆全, 和田 侑輝人, 古閑 晃, 田辺 公一, 後藤 伸之, 大津 史子
    医薬品
    情報学

    2020年 22 巻 1 号 7-16
    発行日: 2020/05/29
    公開日: 2020/06/13
    ジャーナル フリー

    Objective: The purpose of this study was to create a checklist that summarizes checkpoints that should be noted when using the Japanese Adverse Drug Event Report database (JADER). After we created the checklist, we then used it to survey published academic papers that used JADER.

    Method: First, we created a draft checklist for research that uses JADER by citing the report of CIOMS working group VIII “Practical Aspects of Signal Detection in Pharmacovigilance”. Then, we conducted a pilot test and revised the draft checklist. Finally, the checklist was completed after the review by a pharmacoepidemiology expert. The checklist was applied to published academic papers that used JADER, and the fulfill rate of each checkpoints was calculated.

    Results: A “checklist of important points to be noted during research that uses the data mining method in JADER (mainly signal detection by disproportionality analysis)” was created. We also revealed problems with published academic papers that used JADER. For example, some researchers were thought to be inappropriately using JADER as a source of their research while others used an inappropriate version of MedDRA.

    Conclusion: The checklist created in this study summarizes key points that could be noted in research that uses JADER and is thought to contribute to an improvement in quality of research that uses JADER. Additionally, in our investigation of published academic papers that used JADER, we found the possibility that both the role of signal detection and the impact on analysis of JADER using the updated MedDRA version are not well understood.

  • 齋藤 百枝美,
    安藤
    崇仁, 伊神 敬人, 小中原 隆史, 小松 洋平, 高木 友徳, 永井 典子, 橋本 俊英, 丹羽 真一
    医薬品
    情報学

    2018年 19 巻 4 号 172-179
    発行日: 2018年
    公開日: 2018/03/21
    ジャーナル フリー
    Objective: The maintenance and improvement of medication adherence are important in psychiatry.  In the case of patients using home healthcare services, it is necessary to improve their medication adherence through multi-professional collaboration.  However, appropriate methods or measures to provide them with information regarding psychotropics and resolve their problems during home visits have yet to be clarified.  We aimed to promote the appropriate provision of such information in home healthcare services for patients with mental disorders by clarifying the current status and details of information needed during home visits.
    Methods: A questionnaire survey was conducted in April 2016, involving healthcare professionals who worked in 9 facilities providing home-visit services for patients with mental disorders.
    Results: A total of 116 (86 females and 30 males) responded, among whom nurses accounted for the majority, at 81.9%, followed by psychiatric social workers, at 10.3%, and occupational therapists, at 7.8%.  More than 97% of all respondents assessed medication adherence.  Medication guidance tended to be provided within 15 minutes (81.9%) during each home visit, and the most frequent duration of such guidance was 6 to 10 minutes (37.9%).  Patients most frequently asked about adverse drug effects (57.8%), and the health professionals most frequently faced difficulty answering such questions among all the questions asked (46.6%).  Materials needed during home visits included: <brochures explaining the therapeutic and adverse effects of drugs>, <photographs of drugs>, and <a list of generic drugs>.  Some respondents also noted the necessity of materials that are easy to carry.
    Conclusion: The results clarified the details of information to be provided on administering home healthcare services for patients with mental disorders.  As various professionals are engaged in such services, and they are expected to have a certain level of ability to provide information, systems to effectively support information provision by them may be needed.
  • 舘 知也, 野口 義紘, 寺町 ひとみ
    医薬品
    情報学

    2018年 20 巻 1 号 1-11
    発行日: 2018年
    公開日: 2018/06/16
    ジャーナル フリー
    Objective: A medication notebook is developed in order to unitedly manage medication information of patients and is used by writing medication information such as history of ethical drugs, over-the-counter drugs and health foods, anamnesis, history of adverse events and allergy.  Adverse events, interaction and duplication of drugs can be prevented by showing a medication notebook to doctors and pharmacists.
    Data Sources·Study Selection·Data Extraction: In this article, we reviewed literatures regarding preceding studies on the utilization of medication notebooks comprehensively.
    Results·Conclusion: In our review, we could comprehend literature on medication notebooks systematically and could summarize a lot of evidences that confirm the usefulness of medication notebooks.  We need to produce further evidences on medication notebooks to spread medication notebooks.
  • ―服用期間と休薬期間の関係性の解析―
    真野 泰成, 加藤 芳徳, 衛藤 祐子, 齊藤 重光, 今成 得恵, 大内 かおり, 廣澤 伊織, 田島 正教, 生野 登, 山田 治美, 植木 充, 小瀧 一, 旭 満里子
    医薬品
    情報学

    2013年 15 巻 2 号 71-77
    発行日: 2013年
    公開日: 2013/09/05
    ジャーナル フリー
    Objective: Macrolide therapy has been recommended as an effective treatment for pediatric otolaryngology patients with conditions such as chronic sinusitis and otitis media with effusion.  However, in many cases, a relapse may occur after cessation of treatment.  Therefore, patients are compelled to continue taking antibiotics.  In this paper, we examined the relationship between the duration of therapy and period to relapse on the basis of prescription information and literature research.
    Methods: To evaluate the therapeutic doses, we investigated the clinical doses of erythromycin and clarithromycin used for pediatric patients in a community pharmacy from January 2009 to July 2009.  Further, we performed literature searches on the doses of both drugs using Igaku-Chuo-Zasshi databases (from 1983 to 2011) and compared the data obtained with the clinical doses.  Accordingly, the oral doses of macrolides were classified as a low dose or normal dose.  We analyzed the relationship between the administration period and the cessation period, which was defined as the period from the cessation of the treatment to relapse.
    Results: Review of the 17 selected reports and the clinical doses showed that the maximum dose of erythromycin was 15 mg/kg/day and that of clarithromycin was 8 mg/kg/day during therapy.  When both cephem or penicillin antibiotics and low-dose macrolides were taken continuously during the administration period, a weak correlation was observed between the administration period and the cessation period.
    Conclusion: These results may be useful for the appropriate use of antibiotics and for preventing relapse in pediatric otolaryngology patients.
  • 第14回 日本DDS学会奨励賞(基礎)によせて
    安藤
    英紀
    Drug Delivery System
    2022年 37 巻 4 号 334-340
    発行日: 2022/09/25
    公開日: 2022/12/25
    ジャーナル フリー
  • 安藤
    剛, 松元 一明, 横山 雄太, 木津 純子
    日本交通科学学会誌
    2017年 16 巻 1 号 46-51
    発行日: 2017年
    公開日: 2018/03/01
    ジャーナル フリー
    慢性疾患や急性疾患により、治療薬を服用しながら自動車運転をしている患者は多いが、服薬による交通事故の実態は不明である。今回、
    医薬品医療機器総合機構の医薬品
    副作用データベース(JADER)を用いて
    医薬品
    による交通事故の実態について調査した。2004年4月〜2016年3月において、JADERの総登録件数は390,669件で、有害事象としての交通事故は342件であった。被疑薬176薬品のROR(Reporting Odds Ratio)および95%信頼区間(CI)下限値を算出した結果、82薬品においてCIの下限値が1を超えており因果関係が示唆された。被疑薬としては、プラミペキソール塩酸塩水和物が47件と最も多く、そのうち36件が突発的睡眠が併発有害事象であった。次いでゾルピデム酒石酸塩46件、プレガバリン35件、バレニクリン酒石酸塩19件、スルピリド13件等であり、添付文書に自動車運転等に関する警告や禁止が記載されている
    医薬品
    が主であった。高齢化が進み、自動車運転に対する療養指導、服用すべき
    医薬品
    に関する適切な服薬指導は益々重要となる。自動車運転をする患者に対しては、医師や薬剤師が適切にアドバイスする必要があり、その際に、本調査結果は有用な資料の一つとなると考える。
  • 上村 慎子, 水野 くみ子, 黒見 公一, 上野 千恵, 栗田 浩幸, 小和田 和宏, 山本 政利
    日本化粧品技術者会誌
    2008年 42 巻 1 号 36-39
    発行日: 2008/03/20
    公開日: 2010/08/06
    ジャーナル フリー
    ガスクロマトグラフィー (GC) による練り歯磨き中のジエチレングリコール (DEG) の迅速かつ簡易な分析法を開発した。練り歯磨き中のDEGは, 1, 4-ブタンジオールを内標準物質として含有するメタノール溶液で超音波処理により抽出した。メタノール抽出液を遠心, ろ過した後, InertCap 624キャピラリーカラムを用いたGCにより分析した。練り歯磨きにDEGを0.1-1.0%添加した場合の回収率は99.4-103.6%であった。練り歯磨き中のDEGの定量限界は0.05%であった。この方法は他の市販化粧品にも適用することができた。この分析法を用いて, 旅館やホテルで使用される練り歯磨き10検体について分析し, 2検体からDEGを検出した。本分析法が化粧品製造販売業者および輸入販売業者における品質管理に役立つことを期待する。
  • ファルマシア
    2020年 56 巻 5 号 382-383
    発行日: 2020年
    公開日: 2020/05/13
    ジャーナル フリー
    特集:元素多様化による新たな創薬戦略
    特集にあたって:近年,革新的技術の登場により創薬方法論が著しく多様化しているが,低分子
    医薬品
    が持つコストや品質管理における強みを考慮すると,低分子化合物は今後も創薬の王道として君臨するだろう.その低分子
    医薬品
    の開発でも,最近,多様性が意識され始め,これまで
    医薬品
    として利用されていなかったホウ素,ケイ素,重水素などの元素を利用した創薬研究が最近盛んに進められている.また,ハロゲン結合などの新たな相互作用が提唱されたことにより,創薬におけるハロゲン原子の価値が拡大しつつある.本特集号を通じて,
    医薬品
    を構成する元素1つ1つに目が向けられ,成熟した低分子創薬が再び飛躍する契機になることを期待したい.
    表紙の説明:化学の基本は周期表である.学生の頃はそれを一生懸命覚えたものだが,創薬をしながら周期表を見ることはどのくらいあっただろうか.改めて周期表を見直してみると,きっと元素の特徴を生かした新たな創薬戦略が浮かぶことだろう.周期表から飛び出た元素は,汎用元素という先入観や固定概念を捨てて創薬に挑戦し続けた先生方への敬意と,これら元素を含む
    医薬品
    創出への期待である.
  • 坂口 宏志,
    安藤
    友紀, 伊熊 睦博
    レギュラトリーサイエンス学会誌
    2023年 13 巻 2 号 141-147
    発行日: 2023年
    公開日: 2023/05/31
    ジャーナル フリー

    「ICH E8臨床試験の一般指針」は,

    医薬品
    の承認に必要となる臨床試験や臨床開発の進め方について総論的に述べたICHガイドラインである.ICH E8ガイドラインは,1997年に策定されて以来,改定は行われてこなかったが,近年,臨床試験ではより多様なデザインやデータソースが用いられるようになった.また,ICH E8ガイドラインでは取り扱われていない「臨床試験の質」についても,事後的に実施される文書やデータのレビューやモニタリングによってではなく,試験の計画や手順の中に前向きに作り込むことにより向上させることが重要という考えも提唱されつつある.以上を背景とし,今般,ICH E8(R1)“General Considerations for Clinical Trails” としてガイドラインの改定が行われたことから,本稿では,当該ガイドラインの改定の概要およびその作成経緯について,ガイドライン改定にかかわった規制当局の立場から記載する.

  • 安藤
    友紀
    神経治療学
    2022年 39 巻 6 号 S154
    発行日: 2022年
    公開日: 2022/10/20
    ジャーナル フリー
feedback
Top